Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0W4GQ
|
||||
| Former ID |
DNC007084
|
||||
| Drug Name |
3-(2-((E)-3-phenylprop-1-enyl)phenyl)acrylic acid
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [528393] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C36H32O4
|
||||
| Canonical SMILES |
C1=CC=C(C=C1)CC=CC2=CC=CC=C2C=CC(=O)O.C1=CC=C(C=C1)C=CC<br />C2=CC=CC=C2C=CC(=O)O
|
||||
| InChI |
1S/2C18H16O2/c2*19-18(20)14-13-17-11-5-4-10-16(17)12-6-9-15-7-2-1-3-8-15/h1-8,10-14H,9H2,(H,19,20);1-11,13-14H,12H2,(H,19,20)/b12-6+,14-13+;9-6+,14-13+
|
||||
| InChIKey |
QRLAGHDTOFFHIC-UMYPGWKJSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Prostaglandin E2 receptor, EP4 subtype | Target Info | Inhibitor | [528393] | |
| Prostaglandin E2 receptor EP3 subtype | Target Info | Inhibitor | [528393] | ||
| Prostaglandin E2receptor, EP2 subtype | Target Info | Inhibitor | [528393] | ||
| KEGG Pathway | Neuroactive ligand-receptor interaction | ||||
| Inflammatory mediator regulation of TRP channels | |||||
| Renin secretion | |||||
| Pathways in cancerhsa04020:Calcium signaling pathway | |||||
| cAMP signaling pathway | |||||
| Regulation of lipolysis in adipocytes | |||||
| Pathways in cancerhsa04024:cAMP signaling pathway | |||||
| Pathways in cancer | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.